Fierce Biotech January 24, 2023
Helen Floersh

While it remains to be seen how delivery, manufacturing and pricing will play out, Jennifer Doudna, Ph.D., and co-author Joy Wang predict that the next 10 years will see CRISPR technology become faster and cheaper to use for applications like genome sequencing. (LuckyStep48/iStock/Getty Images Plus)

It took five years to sequence the first human genome. Today, it takes less than 24 hours.

Rapid genome sequencing is one of the many advances indebted to CRISPR-Cas9, the powerful gene editing technology that has fundamentally changed research and biomedicine in the 10 years since its advent. In a new review published Jan. 20 in Science by CRISPR pioneer Jennifer Doudna, Ph.D., and Doudna lab doctoral candidate Joy Wang, the researchers lay...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Precision Medicine
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article